ConditionGastric Cancer Stage
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital with Nanjing Medical University
About this trial
Accurate preoperative staging of gastric cancer is of major importance for guiding therapeutic decision-making, preventing both under- and over-treatment. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and dual-energy computed tomography (DECT) in gastric cancer.
Eligibility criteria
Qualifiers
Consecutive patients with preoperative pathologically confirmed GC by endoscopy and preoperative imaging data (DECT/mpMRI) were included.
No contraindications for CT/MRI examination
Written informed consent
Disqualifiers
Patients with a history of previous therapy.
Patients with recurrent gastric cancer
Patients with a history of severe allergy to contrast agents
Patients with imaging artefacts affect the evaluation
Trial design
Treatments tested in this trial
- DECT examination
- mpMRI examination
Treatment groups
222 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov